Rapport
Q&A on the webinar: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance
This Q&A compiles questions asked during the 3 sessions of the webinar on: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance.
Auteurs
Langues
- Anglais
Année de publication
2022
Type
Rapport
Catégories
- Chaîne d'approvisionnement
Maladies
- COVID-19
